Sarepta Therapeutics, Inc. SRPT Business Segments — Income Tax

Similar metrics at other companies

UFPIAll Other Segments — Income Tax Expense Benefit

$904K+35.1%

NFGAll Other — Income Tax

$262K+420%

QCRHAll Other Segments — Income Tax Expense Benefit

-$312K+54.8%

NBT

NBTBAll Other Segments — Income Tax Expense Benefit

$0—

RYANReporting Segment — Income Tax

$6.51M-88.3%

MUROther — Income tax expense (benefit)

-$525K+93.2%

Questions, answered.

What is Sarepta Therapeutics, Inc.'s business segments — income tax?

Sarepta Therapeutics, Inc. (SRPT) reported business segments — income tax of $2.8M in Q4 2025.

How has Sarepta Therapeutics, Inc.'s business segments — income tax changed year-over-year?

Sarepta Therapeutics, Inc.'s business segments — income tax decreased by 56.2% year-over-year, from $6.38M to $2.8M.

What is the long-term trend for Sarepta Therapeutics, Inc.'s business segments — income tax?

Over 3 years (2022 to 2025), Sarepta Therapeutics, Inc.'s business segments — income tax has grown at a -6.1% compound annual growth rate (CAGR), from $13.53M to $11.19M.

What does business segments — income tax mean?

This metric represents the total provision for income taxes allocated to the specific business segment. It reflects the tax burden associated with the segment's operational earnings and jurisdictional tax obligations. Monitoring this helps investors understand the effective tax rate impact on the segment's bottom-line contribution.